IL17A and acute graft versus host disease: To determine whether GMSCs could suppress acute GVHD through controlling cytokine production by staining with IFN-γ, IL-17, IL-4, TNF-α, IL-2, and IL-10, we detected the production of cytokines after injecting 15 days.